Immunomodulatory analogues of thalidomide in the treatment of multiple myeloma

Clinical Lymphoma & Myeloma
Revathi SuppiahMohamad Hussein

Abstract

The design of innovative, more effective, less toxic therapy for multiple myeloma (MM) is emerging in parallel to a better understanding of the underlying pathophysiology of this common hematologic malignancy. Thalidomide has changed the treatment paradigm for patients with myeloma. Its efficacy, however, has been compromised to some degree by its side effects. Immunomodulatory drugs (IMiDs) are structural and functional analogues of thalidomide that were specifically designed to produce new agents with enhanced immunomodulating and anticancer properties but with less toxicity. In this article, we review the clinical trial development of second-generation IMiDs lenalidomide and CC-4047. Both agents demonstrate potent activity with manageable toxicities and provide another treatment opportunity for patients with MM.

References

May 24, 1984·The New England Journal of Medicine·B BarlogieR Alexanian
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·R J D'AmatoJ Folkman
Feb 17, 1994·The New England Journal of Medicine·R Alexanian, M Dimopoulos
Nov 24, 1999·The New England Journal of Medicine·S SinghalB Barlogie
Nov 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S Vincent RajkumarThomas E Witzig
Dec 3, 2002·Nature Reviews. Cancer·Teru Hideshima, Kenneth C Anderson
Dec 31, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Donna WeberRaymond Alexanian
May 9, 2003·The New England Journal of Medicine·J Anthony ChildUNKNOWN Medical Research Council Adult Leukaemia Working Party
Apr 2, 2004·Nature Reviews. Cancer·J Blake BartlettAngus G Dalgleish
Apr 20, 2004·Blood·Teru HideshimaKenneth C Anderson
Jul 14, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S A ScheyA G Dalgleish

❮ Previous
Next ❯

Citations

Dec 30, 2010·The Journal of Biological Chemistry·Chad C BjorklundRobert Z Orlowski
Aug 26, 2014·Current Hematologic Malignancy Reports·Isabel Ruth PreeshagulTomer M Mark
Aug 16, 2015·Current Hematologic Malignancy Reports·Karie D Runcie, Tomer M Mark
Nov 21, 2008·European Journal of Haematology·Francesca PatriarcaAntonio Palumbo
Aug 2, 2015·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Yaobin LiuGuoqiang Xu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Bosnian Journal of Basic Medical Sciences
Gordan Srkalovic, Mohamad Hussein
Current Hematologic Malignancy Reports
M Q Lacy
Expert Opinion on Investigational Drugs
Neeraj Saini, A Mahindra
Expert Review of Hematology
Swati Andhavarapu, Vivek Roy
Anti-cancer Agents in Medicinal Chemistry
Nishant Tageja
© 2021 Meta ULC. All rights reserved